Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus

Scandinavian Journal of Immunology

Volumn 47, Issue 3, 1998, Pages 277-279

  Mustonen, J ^a,d   Partanen, J ^b   Kanerva, M ^c   Pietila K ^a   Vapalahti, O ^c   Pasternack, A ^a   Vaheri, A ^c  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b Tissue Typing Laboratory   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; HLA B8 ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HAPLOTYPE; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUUMALA VIRUS; ZOONOSIS;

ADULT; AGED; FEMALE; HANTAVIRUS; HANTAVIRUS INFECTIONS; HAPLOTYPES; HLA-B27 ANTIGEN; HUMANS; MALE; MIDDLE AGED;

EID: 0031955512     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00302.x     Document Type: Article

References (16)

1. Lee HW, Lee PW, Baek LJ, Chu YK. Geographical distribution of hemorrhagic fever with renal syndrome and hantaviruses. Arch Virol Suppl 1990;1:5-18.
2. Settergren B. Nephropathia epidemica (hemorrhagic fever with renal syndrome) in Scandinavia. Rev Infect Dis 1991;13:736-44.
3. Mustonen J, Brummer-Korvenkontio M, Hedman K, Pasternack A, Pietilä K, Vaheri A. Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis 1994;26:7-13.
4. Mustonen J, Helin H, Pietilä K et al. Renal biopsy findings and clinicopathologic correlations in nephropathia epidemica. Clin Nephrol 1994;41:121-6.
5. Mustonen J, Partanen J, Kanerva M et al. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int 1996;49:217-21.
6. Steel CM, Ludlam CA, Beatson D et al. HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. Lancet 1988;i:1185-8.
7. McNeil AJ, Yap PL, Gore SM et al. Association of HLA types Al-B8-DR3 and B27 with rapid and slow progression of HIV disease. QJ Med 1996;89:177-85.
8. Hedman K, Vaheri A, Brummer-Korvenkontio M. Rapid diagnosis of hantavirus disease with IgG avidity assay. Lancet 1991;338:1353-6.
9. Westman P, Kuismin T, Partanen J, Koskimies S. An HLA-DR-typing protocol using group-specific PCR-amplification followed by restriction enzyme digests. Eur J Immunogenet 1993;20:103-9.
10. Ota M, Seki T, Nomura N. Modified PCR-RFLP method for HLA-DPB1 and -DQA1 genotyping. Tissue Antigens 1991;38:60-71.
11. Kimura A, Sasazuki T. In: HLA 1991, Sasazuki T, ed. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. Oxford: Oxford University Press, 1992, pp. 397-419.
12. Lokki M-L, Julin M. HLA-A, B, C gene and haplotype frequencies in the Finnish population. Tissue Antigens 1982;20:239-50.
13. Hashimoto S, McCombs CC, Michalski JP. Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3 in clinically healthy individuals. Clin Exp Immunol 1989;76:317-23.
14. Candore G, Cigna D, Gervasi F, Colucci AT, Modica MA, Caruso C. In vitro cytokine production by HLA-B8, DR3 positive subjects. Autoimmunity 1994;18:121-32.
15. Egea E, Iglesias A, Salazar M et al. The cellular basis for lack of antibody response to hepatitis B vaccine in humans. J Exp Med 1991;173:531-8.
16. Ohno S. How cytotoxic T cells manage to discriminate nonself from self at the nonapeptide level. Proc Natl Acad Sci 1992;89:4643-7.